The rating downgrade to Baa2 reflects Winthrop’s weaker financial performance and low case flow generation in 2013, in addition to the organization’s proposed additional debt of $60 million to fund various strategic capital projects. Winthrop’s operating cash flow has declined year-over-year, with a low 4.4 percent operating cash flow margin in 2013.
The rating outlook for Winthrop still remains stable with the Baa2 rating due to the organization’s size, strong revenue growth, patient volume growth and expectation of stable financial performance going forward.
More Articles on Hospital Credit Ratings:
S&P: Nonprofit Hospitals Improve Pension Funding
11 Hospitals Receive Credit Downgrades in Past Month
21 Hospitals and Health Systems With Strong Finances
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
